Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 1/2014

Open Access 01-12-2014 | Poster presentation

PB.20. Audit of 5 years of routine screening mammography of the reconstructed breast

Authors: A Ray, L McNeilly, A Newland, S Flais

Published in: Breast Cancer Research | Special Issue 1/2014

Login to get access

Excerpt

In 2008, allowing for an increase in the number of women treated with mastectomy and immediate reconstruction, the decision at our institution was made to carry out mammography of the native and the reconstructed breast at follow-up. A literature review at that time revealed that mammography of the reconstructed breast may help diagnose recurrence before any symptom. This local practice is now audited to evaluate its impact, and whether it should continue. …
Metadata
Title
PB.20. Audit of 5 years of routine screening mammography of the reconstructed breast
Authors
A Ray
L McNeilly
A Newland
S Flais
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2014
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr3724

Other articles of this Special Issue 1/2014

Breast Cancer Research 1/2014 Go to the issue

Poster presentation

PB.8. Ultrasound-guided excision of fibroadenomas: 9 years' experience in a British breast unit

Oral presentation

Digital breast tomosynthesis improves the accuracy of the diagnosis of circumscribed lesions because of increase of margin visibility

Poster presentation

PB.7. Large-volume biopsy for B3 lesions without atypia: is once enough?

Poster presentation

PB.31. Occult breast carcinoma: an experience at a single unit

Poster presentation

PB.44. Do qualitative patterns of stiffness help differentiate benign from malignant breast masses of similar stiffness during shear wave elastography?

Poster presentation

PB.28. Determination of recall rates for assessment in women undergoing annual surveillance breast MRI: is a rate <10% achievable?
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits